ethylisopropylamiloride has been researched along with Chronic Disease in 1 studies
ethylisopropylamiloride: structure in first source
ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Quinn, DA | 1 |
| Du, HK | 1 |
| Thompson, BT | 1 |
| Hales, CA | 1 |
1 other study available for ethylisopropylamiloride and Chronic Disease
| Article | Year |
|---|---|
Amiloride analogs inhibit chronic hypoxic pulmonary hypertension.
Topics: Amiloride; Animals; Blood Pressure; Cell Division; Chronic Disease; Hematocrit; Hypertension, Pulmon | 1998 |